Efficacité et tolérance du cyclophosphamide dans le traitement de fond des formes progressives de la sclérose en plaques

Our results suggest that the CPM is efficient in progressive multiple sclerosis; however, its place must be reconsidered before establishing an international consensus for treatment; open label studies are needed to validate the present findings.